It is hypothesized that the decreased expression of CD200 in these misshapen cells may lead to the inefficient interaction between CD200 and CD200R, which subsequently contributes to microglial activation and the concomitant chronic inflammation in epileptogenic lesions of FCD IIb and TSC patients. This evidence concerns the gene CD200R1 and tuberous sclerosis.